Evidence map›Paper›PMID 40378829›Full record

ReviewMolecular cell2025

Regulation of RNA polymerase II transcription through re-initiation and bursting.

Michael Nagel, Dylan J Taatjes

Abstract readReview
In one paragraph

Review in Molecular cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. The molecular basis of transcription initiation by RNA polymerase II.Nature reviews. Molecular cell biology · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael NagelDepartment of Biochemistry, University of Colorado, Boulder, CO 80303, USA.
Dylan J TaatjesDepartment of Biochemistry, University of Colorado, Boulder, CO 80303, USA. Electronic address: taatjes@colorado.edu.

Funding

Supplemental request for MAX-TL Ultracentrifuge and rotorR35GM139550 · NIGMS · UNIVERSITY OF COLORADO · PI Dylan J Taatjes · 2021 to 2026
$3.8M
Mediator kinases as interferon antagonists in Down SyndromeR01AI156739 · NIAID · UNIVERSITY OF COLORADO · PI TAATJES, DYLAN J · 2020 to 2024
$2.4M
NIAID NIH HHS R01 AI156739NIGMS NIH HHS R35 GM139550
6 · The paper itself

Abstract

The regulation of RNA polymerase II (RNAPII) activity requires orchestrated responses among genomic regulatory sequences and an expansive set of proteins and protein complexes. Despite intense study over five decades, mechanistic insights continue to emerge. Within the past 10 years, live-cell imaging and single-cell transcriptomics experiments have yielded new information about enhancer-promoter communication, transcription factor dynamics, and the kinetics of RNAPII transcription activation. These insights have established RNAPII re-initiation and bursting as a common regulatory phenomenon with widespread implications for gene regulation in health and disease. Here, we summarize regulatory strategies that help control RNAPII bursting in eukaryotic cells, which is defined as short periods of active transcription followed by longer periods of inactivity. We focus on RNAPII re-initiation (i.e., a "burst" of two or more polymerases that initiate from the same promoter), with an emphasis on molecular mechanisms, open questions, and controversies surrounding this distinct regulatory stage.

Indexed as

RNA Polymerase IITranscription, GeneticTranscription Initiation, GeneticAnimalsGene Expression RegulationHumansPromoter Regions, GeneticTranscriptional ActivationTranscription FactorsRNA Polymerase IITranscription Factorsburst frequencyburstingburst sizeclusteringenhancerIDRintrinsically disordered regionlive-cell imagingMediatorpre-initiation complexpromoterre-initiationRNA polymerase IIstochasticTFIIDtranscriptiontranscription factor

Identifiers

PMID40378829
PMCPMC12088388

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.